Viemed Healthcare, Inc. VMD 深 沪
已收盘 05-08 16:00:00 美东时间
8.94
-0.270
-2.93%
华盛通- 最 高9.16
- 今 开9.14
- 成交量 24.86万股
- 最 低 8.852
- 昨 收 9.21
- 总市值 3.44亿
- 52周最高 10.18
- 市盈率 静 24.44
- 换手率 0.65%
- 52周最低 5.93
- 委 比 87.34%
- 总股本 3848.36万
- 历史最高 12.0099
- 量 比 0.69
- 振 幅 3.34%
- 历史最低 2.44
- 每 手 1
- 风险率 1.08%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Viemed forecasts $312M-$320M 2026 net revenue while tightening net CapEx to 9%-10.5%
Earnings Call Insights: Viemed Healthcare, Inc. (VMD) Q1 2026 Management View “This past quarter demonstrated what consistent execution looks like across our entire platform,” said (CEO & Director Cas...
05-07 03:32
Viemed Healthcare Raises FY2026 Sales Guidance from $310.000M-$320.000M to $312.000M-$320.000M vs $315.450M Est
Viemed Healthcare (NASDAQ:VMD) raises FY2026 sales outlook from $310.000 million-$320.000 million to $312.000 million-$320.000 million vs $315.450 million estimate.
05-06 05:03
Viemed Healthcare Q1 EPS $0.06 Misses $0.09 Estimate, Sales $75.414M Beat $74.400M Estimate
Viemed Healthcare (NASDAQ:VMD) reported quarterly earnings of $0.06 per share which missed the analyst consensus estimate of $0.09 by 33.33 percent. This is unchanged from the same period last year. The company reported
05-06 05:03
Viemed Healthcare Q1 Earnings Preview
Viemed Healthcare (VMD) is scheduled to announce Q1 earnings results on Wednesday, May 6th, before market open. The consensus EPS Estimate is $0.09 (+50.0% Y/Y) and the consensus Revenue Estimate is $...
05-06 03:27
Earnings Scheduled For May 5, 2026
Companies Reporting Before The Bell • Repligen (NASDAQ:RGEN) is projected to re...
05-05 19:12
10 high-profitability small-cap stocks that are outperforming in 2026
A notable shift is underway in the small-cap market in 2026: profitable Russell 2000 companies are decisively outperforming their non-profitable counterparts, with profitable stocks up approximately 8...
04-14 04:45
Viemed Healthcare reports mixed Q4 results; introduces FY26 outlook
Viemed Healthcare press release (VMD): Q4 GAAP EPS of $0.14 beats by $0.05. Revenue of $76.2M (+25.5% Y/Y) misses by $1.15M. Adjusted EBITDA for the quarter and year ended December 31, 2025 totaled $1...
03-05 12:48
Viemed Healthcare Sees FY2026 Sales $310.000M-$320.000M vs $332.550M Est.
Viemed Healthcare (NASDAQ:VMD) sees FY2026 sales of $310.000 million-$320.000 million vs $332.550 million analyst estimate.
03-05 05:50
Viemed Healthcare Q4 EPS $0.14 Beats $0.13 Estimate, Sales $76.181M Miss $77.700M Estimate.
Viemed Healthcare (NASDAQ:VMD) reported quarterly earnings of $0.14 per share which beat the analyst consensus estimate of $0.13 by 12 percent. This is a 40 percent increase over earnings of $0.10 per share from the same
03-05 05:49
Viemed Healthcare Board Authorizes 1.93M Common Stock Buyback Plan Through March 2027
Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, today announced that its Board of Directors has
03-05 05:48
